Sign In
2 Jul 2013 09:41

2 July 2013
Immunodiagnostic Systems Holdings Plc
Directors' share purchases
Immunodiagnostic Systems Holdings plc (AIM: IDH), a leading producer of diagnostic testing kits and automated systems for the clinical and research markets, announces that it was informed on 1 July, 2013 of the following Directors' share purchases made earlier that day:
Â
 | Number of ordinary shares acquired | Share price | Resultant holding | Resultant %(1) |
Patrik Dahlen | 5,719 | 450p | 44,751 | 0.16% |
Chris Yates | 500 | 459p | 5,500 | 0.02% |
(1) Based on 28,870,361 ordinary shares in issue
Â
For further information:
Immunodiagnostic Systems Holdings PLC | Tel : +44 (0)191 519 0660 |
Patrik Dahlen, Chief Executive Officer | Â |
Chris Yates, Group Finance Director | Â |
 |  |
Peel Hunt LLP | Tel : +44 (0)207 418 8900 |
James Steel | Â |
Dr Vijay Barathan | Â |
 |  |
 FTI Consulting |  Tel : +44 (0)207 831 3113 |
Ben Atwell | Â |
Simon Conway | Â |
Mo Noonan | Â |
Â
About Immunodiagnostic Systems Holdings PLC
The Group operates in the in-vitro diagnostics ("IVD") market by designing, manufacturing and selling immunoassay kits as well as its automated analyser, the IDS-iSYS System. The IDS product range is used to measure or detect particular substances within a sample, thus aiding the diagnosis or monitoring of a disease or providing information for research studies.
http://www.idsplc.com
Â
Follow the stocks
